Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simultaneous vs Sequential Zoladex with Chemotherapy in Premenopausal Breast Cancer
NCT01712893Phase 3Completed
- Sponsor
- Fudan University
- Start
- Jun 2009
- Primary completion
- Aug 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of goserelin in breast cancer, sponsored by Fudan University. Started Jun 2009; status: completed.
02
Drugs
goserelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01712893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01712893.